Works by Ellis, Catherine

Results: 64
    1
    2
    3

    A Phase I, First‐in‐Human Study of GSK2849330, an Anti‐HER3 Monoclonal Antibody, in HER3‐Expressing Solid Tumors.

    Published in:
    Oncologist, 2021, v. 26, n. 10, p. e1844, doi. 10.1002/onco.13860
    By:
    • Gan, Hui K.;
    • Millward, Michael;
    • Jalving, Mathilde;
    • Garrido‐Laguna, Ignacio;
    • Lickliter, Jason D.;
    • Schellens, Jan H.M.;
    • Lolkema, Martijn P.;
    • Van Herpen, Carla L.M.;
    • Hug, Bruce;
    • Tang, Lihua;
    • O'Connor‐Semmes, Robin;
    • Gagnon, Robert;
    • Ellis, Catherine;
    • Ganji, Gopinath;
    • Matheny, Christopher;
    • Drilon, Alexander
    Publication type:
    Article
    4
    5

    Efficacy, safety, pharmacokinetics and biomarker findings in patients with HER2-positive advanced or metastatic breast cancer treated with lapatinib in combination with capecitabine: results from 51 Japanese patients treated in a clinical study.

    Published in:
    Breast Cancer (13406868), 2015, v. 22, n. 2, p. 192, doi. 10.1007/s12282-013-0475-1
    By:
    • Iwata, Hiroji;
    • Fujii, Hirofumi;
    • Masuda, Norikazu;
    • Mukai, Hirofumi;
    • Nishimura, Yuichiro;
    • Katsura, Koichi;
    • Ellis, Catherine;
    • Gagnon, Robert;
    • Nakamura, Seigo
    Publication type:
    Article
    6
    7
    8
    9

    Prospective Biomarker Analysis of the Randomized CHER-LOB Study Evaluating the Dual Anti-HER2 Treatment With Trastuzumab and Lapatinib Plus Chemotherapy as Neoadjuvant Therapy for HER2-Positive Breast Cancer.

    Published in:
    Oncologist, 2015, v. 20, n. 9, p. 1001, doi. 10.1634/theoncologist.2015-0138
    By:
    • Guarneri, Valentina;
    • Dieci, Maria Vittoria;
    • Frassoldati, Antonio;
    • Maiorana, Antonino;
    • Ficarra, Guido;
    • Bettelli, Stefania;
    • Tagliafico, Enrico;
    • Bicciato, Silvio;
    • Generali, Daniele Giulio;
    • Cagossi, Katia;
    • Bisagni, Giancarlo;
    • Sarti, Samanta;
    • Musolino, Antonino;
    • Ellis, Catherine;
    • Crescenzo, Rocco;
    • Conte, PierFranco
    Publication type:
    Article
    10
    11

    Momelotinib versus Continued Ruxolitinib or Best Available Therapy in JAK Inhibitor-Experienced Patients with Myelofibrosis and Anemia: Subgroup Analysis of SIMPLIFY-2.

    Published in:
    Advances in Therapy, 2024, v. 41, n. 9, p. 3722, doi. 10.1007/s12325-024-02928-4
    By:
    • Harrison, Claire N.;
    • Vannucchi, Alessandro M.;
    • Recher, Christian;
    • Passamonti, Francesco;
    • Gerds, Aaron T.;
    • Hernandez-Boluda, Juan Carlos;
    • Yacoub, Abdulraheem;
    • Sirhan, Shireen;
    • Ellis, Catherine;
    • Patel, Bharat;
    • Strouse, Bryan;
    • Platzbecker, Uwe
    Publication type:
    Article
    12
    13

    Phase I dose-escalation trial of the oral AKT inhibitor uprosertib in combination with the oral MEK1/MEK2 inhibitor trametinib in patients with solid tumors.

    Published in:
    2020
    By:
    • Tolcher, Anthony W.;
    • Kurzrock, Razelle;
    • Valero, Vincente;
    • Gonzalez, Rene;
    • Heist, Rebecca S.;
    • Tan, Antoinette R.;
    • Means-Powell, Julie;
    • Werner, Theresa L.;
    • Becerra, Carlos;
    • Wang, Chenxi;
    • Leonowens, Cathrine;
    • Kalyana-Sundaram, Shanker;
    • Kleha, Joseph F.;
    • Gauvin, Jennifer;
    • D'Amelio, Anthony M.;
    • Ellis, Catherine;
    • Ibrahim, Nageatte;
    • Yan, Li;
    • D'Amelio, Anthony M Jr
    Publication type:
    journal article
    14
    15
    16
    17
    18
    19
    20

    Momelotinib vs. ruxolitinib in myelofibrosis patient subgroups by baseline hemoglobin levels in the SIMPLIFY-1 trial.

    Published in:
    Leukemia & Lymphoma, 2024, v. 65, n. 7, p. 965, doi. 10.1080/10428194.2024.2328800
    By:
    • Gupta, Vikas;
    • Oh, Stephen;
    • Devos, Timothy;
    • Dubruille, Viviane;
    • Catalano, John;
    • Somervaille, Tim C. P.;
    • Platzbecker, Uwe;
    • Giraldo, Pilar;
    • Kosugi, Hiroshi;
    • Sacha, Tomasz;
    • Mayer, Jiri;
    • Illes, Arpad;
    • Ellis, Catherine;
    • Wang, Zhaohui;
    • Gonzalez Carreras, Francisco J.;
    • Strouse, Bryan;
    • Mesa, Ruben
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28

    The benefit of evolving multidisciplinary care in ALS: a diagnostic cohort survival comparison.

    Published in:
    Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2017, v. 18, n. 7/8, p. 569, doi. 10.1080/21678421.2017.1349151
    By:
    • Martin, Sarah;
    • Trevor-Jones, Emma;
    • Khan, Sabyha;
    • Shaw, Keelan;
    • Marchment, Deepti;
    • Kulka, Anna;
    • Ellis, Catherine E;
    • Burman, Rachel;
    • Turner, Martin R.;
    • Carroll, Liam;
    • Mursaleen, Leah;
    • Leigh, P. Nigel;
    • Shaw, Christopher E.;
    • Pearce, Neil;
    • Stahl, Daniel;
    • Al-Chalabi, Ammar
    Publication type:
    Article
    29

    Psychological as well as illness factors influence acceptance of non-invasive ventilation (NIV) and gastrostomy in amyotrophic lateral sclerosis (ALS): A prospective population study.

    Published in:
    Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2014, v. 15, n. 5/6, p. 376, doi. 10.3109/21678421.2014.886700
    By:
    • Martin, Naomi H.;
    • Landau, Sabine;
    • Janssen, Anna;
    • Lyall, Rebecca;
    • Higginson, Irene;
    • Burman, Rachel;
    • McCrone, Paul;
    • Sakel, Mohammed;
    • Ellis, Catherine M.;
    • Shaw, Christopher E.;
    • Al-Chalabi, Ammar;
    • Leigh, P. Nigel;
    • Goldstein, Laura H.
    Publication type:
    Article
    30
    31

    Neuroendocrine neoplasms: Consensus on a patient care pathway.

    Published in:
    Journal of Neuroendocrinology, 2024, v. 36, n. 4, p. 1, doi. 10.1111/jne.13380
    By:
    • Hooper, Jessica;
    • Jervis, Nikie;
    • Morgan, Lucy;
    • Beckett, Vivienne;
    • Hand, Philippa;
    • Higgs, Kate;
    • Munir, Alia;
    • Prinn, Jenny;
    • Pritchard, D Mark;
    • Sarker, Debashis;
    • Srirajaskanthan, Raj;
    • Ellis, Catherine Bouvier
    Publication type:
    Article
    32

    Orphan G-protein-coupled receptors: the next generation of drug targets?

    Published in:
    British Journal of Pharmacology, 1998, v. 125, n. 7, p. 1387, doi. 10.1038/sj.bjp.0702238
    By:
    • Wilson, Shelagh;
    • Bergsma, Derk J.;
    • Chambers, Jon K.;
    • Muir, Alison I.;
    • Fantom, Kenneth G. M.;
    • Ellis, Catherine;
    • Murdock, Paul R.;
    • Herrity, Nicole C.;
    • Stadel, Jeffrey M.
    Publication type:
    Article
    33
    34
    35
    36
    37

    Impact of serum HER2, TIMP-1, and CAIX on outcome for HER2+ metastatic breast cancer patients: CCTG MA.31 (lapatinib vs. trastuzumab).

    Published in:
    Breast Cancer Research & Treatment, 2017, v. 164, n. 3, p. 571, doi. 10.1007/s10549-017-4273-x
    By:
    • Ho, Diep;
    • Huang, Jessica;
    • Chapman, Judith-Anne;
    • Leitzel, Kim;
    • Ali, Suhail;
    • Shepherd, Lois;
    • Parulekar, Wendy;
    • Ellis, Catherine;
    • Crescnzo, Rocco;
    • Zhu, Liting;
    • Virk, Shakeel;
    • Nomikos, Dora;
    • Aparicio, Samuel;
    • Gelmon, Karen;
    • Carney, Walter;
    • Lipton, Allan
    Publication type:
    Article
    38
    39
    40
    41
    42

    Momelotinib: Mechanism of action, clinical, and translational science.

    Published in:
    CTS: Clinical & Translational Science, 2024, v. 17, n. 8, p. 1, doi. 10.1111/cts.70018
    By:
    • Vlasakakis, Georgios;
    • McCabe, Michael T.;
    • Ho, Yu Liu;
    • Ferron‐Brady, Geraldine;
    • Martin, Paul;
    • Bentley, Darren;
    • Ellis, Catherine;
    • Antonysamy, Mary;
    • Visser, Sandra A. G.
    Publication type:
    Article
    43
    44
    45
    46
    47

    Association of phosphatase and tensin homolog low and phosphatidylinositol 3-kinase catalytic subunit alpha gene mutations on outcome in human epidermal growth factor receptor 2 positive metastatic breast cancer patients treated with first-line lapatinib plus paclitaxel or paclitaxel alone

    Published in:
    Breast Cancer Research, 2014, v. 16, n. 4, p. 1, doi. 10.1186/s13058-014-0405-y
    By:
    • Binghe Xu;
    • Zhongzhen Guan;
    • Zhenzhou Shen;
    • Zhongshen Tong;
    • Zefei Jiang;
    • Junlan Yang;
    • DeSilvio, Michelle;
    • Russo, Mark;
    • Leigh, Meggan;
    • Ellis, Catherine
    Publication type:
    Article
    48
    49
    50